Table 2.
Medical history of patients with CKD-associated anemia (safety analysis set).
| Medical history | PD (n = 676) | HD (n = 851) | NDD (n = 494) | Overall (n = 2021) |
|---|---|---|---|---|
| Diabetes mellitus | 128 (18.9) | 255 (30.0) | 169 (34.2) | 552 (27.3) |
| Type 1 diabetes mellitus | 5 (0.7) | 12 (1.4) | 6 (1.2) | 23 (1.1) |
| Type 2 diabetes mellitus | 118 (17.5) | 233 (27.4) | 156 (31.6) | 507 (25.1) |
| Other | 5 (0.7) | 12 (1.4) | 7 (1.4) | 24 (1.2) |
| Cardio-cerebral vascular disease | 659 (97.5) | 835 (98.1) | 454 (91.9) | 1948 (96.4) |
| Hypertension | 656 (97.0) | 826 (97.1) | 450 (91.1) | 1932 (95.6) |
| Coronary atherosclerotic heart disease | 85 (12.6) | 205 (24.1) | 85 (17.2) | 375 (18.6) |
| Myocardial infarction | 6 (0.9) | 18 (2.1) | 9 (1.8) | 33 (1.6) |
| Stroke and transient ischemic attack | 56 (8.3) | 111 (13.0) | 61 (12.3) | 228 (11.3) |
| Heart failure | 146 (21.6) | 207 (24.3) | 44 (8.9) | 397 (19.6) |
| Atrial fibrillation | 5 (0.7) | 24 (2.8) | 6 (1.2) | 35 (1.7) |
| Venous thromboembolic events | 7 (1.0) | 56 (6.6) | 7 (1.4) | 70 (3.5) |
| Arteriovenous fistula site complication | 2 (0.3) | 31 (3.6) | 0 | 33 (1.6) |
| Malignant neoplasm | 4 (0.6) | 11 (1.3) | 9 (1.8) | 24 (1.2) |
CKD: Chronic kidney disease; HD: Hemodialysis; NDD: Non-dialysis-dependent; PD: Peritoneal dialysis.